Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies

  • Email
  • Help

Document details

Download document Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies
Reference number EMA/CHMP/292464/2014
Status draft: consultation closed
First published 2014-06-17
Last updated 2014-06-17

Summary

The importance of the patient’s point of view on their health status is fully acknowledged and such information may in principle be used in drawing regulatory conclusions regarding treatment effects. This reflection paper on the use of patient reported outcome (PRO) measures in patients with malignancies focuses on the value of these data from a regulatory perspective.